1. Home
  2. RETO vs XRTX Comparison

RETO vs XRTX Comparison

Compare RETO & XRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RETO

ReTo Eco-Solutions Inc.

N/A

Current Price

$0.76

Market Cap

2.6M

ML Signal

N/A

Logo XORTX Therapeutics Inc.

XRTX

XORTX Therapeutics Inc.

N/A

Current Price

$0.45

Market Cap

2.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RETO
XRTX
Founded
1999
2011
Country
China
Canada
Employees
N/A
N/A
Industry
Multi-Sector Companies
Pharmaceuticals and Biotechnology
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6M
2.7M
IPO Year
2016
2018

Fundamental Metrics

Financial Performance
Metric
RETO
XRTX
Price
$0.76
$0.45
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
491.3K
55.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.55
$0.37
52 Week High
$5.77
$1.41

Technical Indicators

Market Signals
Indicator
RETO
XRTX
Relative Strength Index (RSI) 40.47 48.79
Support Level $0.57 $0.37
Resistance Level $1.23 $0.58
Average True Range (ATR) 0.17 0.04
MACD 0.02 0.01
Stochastic Oscillator 20.48 60.47

Price Performance

Historical Comparison
RETO
XRTX

About RETO ReTo Eco-Solutions Inc.

ReTo Eco-Solutions Inc is a manufacturer and distributor of eco-friendly construction materials and fly ash, as well as equipment used to produce these eco-friendly construction materials. The company engaged in providing consultation, design, project implementation, and construction of urban ecological environments for capturing, controlling, and reusing rainwater. It operates through two segments, namely Machinery and Equipment sales, and Technology Consulting and other services. The company earns its revenue from the Machinery and Equipment sales segment. Geographically, it derives a majority of its revenue from China.

About XRTX XORTX Therapeutics Inc.

XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.

Share on Social Networks: